The New Zealand experience of varroa invasion highlights research opportunities for Australia.

The Varroa mite (Varroa destructor) is implicated as a major disease factor in honey bee (Apis mellifera) populations worldwide. Honey bees are extensively relied upon for pollination services, and in countries such as New Zealand and Australia where honey bees have been introduced specifically for commercial pollinator services, the economic effects of any decline in honey bee numbers are predicted to be profound. V. destructor established in New Zealand in 2000 but as yet, Australia remains Varroa-free. Here we analyze the history of V. destructor invasion and spread in New Zealand and discuss the likely long-term impacts. When the mite was discovered in New Zealand, it was considered too well established for eradication to be feasible. Despite control efforts, V. destructor has since spread throughout the country. Today, assessing the impacts of the arrival of V. destructor in this country is compromised by a paucity of data on pollinator communities as they existed prior to invasion. Australia's Varroa-free status provides a rare and likely brief window of opportunity for the global bee research community to gain understanding of honey bee-native pollinator community dynamics prior to Varroa invasion.

Antimicrobials in beekeeping.

The bee diseases American and European foulbrood and nosemosis can be treated with anti-infectious agents. However, in the EU and the USA the use of these agents in beekeeping is strictly regulated due to the lack of tolerance (e.g. Maximum Residue Limit) for residues of antibiotics and chemotherapeutics in honey. This article reviews the literature dealing with antimicrobials of interest in apiculture, stability of these antimicrobials in honey, and disposition of the antimicrobials in honeybee hives.